Works matching IS 15228517 AND DT 2021 AND VI 23 AND IP 3
Results: 26
Corrigendum.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 508, doi. 10.1093/neuonc/noy171
- Publication type:
- Article
Corrigendum.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 523, doi. 10.1093/neuonc/noy106
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 352, doi. 10.1093/neuonc/noab043
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 524, doi. 10.1093/neuonc/noab042
- Publication type:
- Article
Reimagining external beam radiotherapy for glioblastoma: "old beam, new trick".
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 345, doi. 10.1093/neuonc/noab008
- By:
- Publication type:
- Article
Radiation therapy to the developing brain: advanced technology is ready for robust optimization parameters.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 350, doi. 10.1093/neuonc/noab007
- By:
- Publication type:
- Article
Early results from the CODEL trial for anaplastic oligodendrogliomas: is temozolomide futile?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 347, doi. 10.1093/neuonc/noab006
- By:
- Publication type:
- Article
Targeting phospholipid metabolism for glioblastoma therapy.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 343, doi. 10.1093/neuonc/noaa309
- By:
- Publication type:
- Article
Role of surgery for glioblastoma: response to letters from Dr. Gerritsen and his colleagues and Dr. Vargas Lopez.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 506, doi. 10.1093/neuonc/noaa305
- By:
- Publication type:
- Article
Stemming the growth of pediatric gliomas through histone modification.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 341, doi. 10.1093/neuonc/noaa302
- By:
- Publication type:
- Article
The actinomycin D molecule docks to a hydrophilic section of the SOX2 high-mobility group (HMG) domain.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 500, doi. 10.1093/neuonc/noaa299
- By:
- Publication type:
- Article
Maximizing extent of resection while minimizing the risk of neurological morbidity in glioma patients: a novel grading scale to translate these surgical goals into a merged onco-functional clinical outcome.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 504, doi. 10.1093/neuonc/noaa288
- By:
- Publication type:
- Article
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 502, doi. 10.1093/neuonc/noaa287
- By:
- Publication type:
- Article
Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 356, doi. 10.1093/neuonc/noaa277
- By:
- Publication type:
- Article
A broad perspective on evaluating bias in the neuro-oncology workplace.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 498, doi. 10.1093/neuonc/noaa286
- By:
- Publication type:
- Article
PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 387, doi. 10.1093/neuonc/noaa255
- By:
- Publication type:
- Article
Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 376, doi. 10.1093/neuonc/noaa249
- By:
- Publication type:
- Article
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 468, doi. 10.1093/neuonc/noaa240
- By:
- Publication type:
- Article
Intellectual changes after radiation for children with brain tumors: which brain structures are most important?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 487, doi. 10.1093/neuonc/noaa217
- By:
- Publication type:
- Article
TGF-β1 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 435, doi. 10.1093/neuonc/noaa198
- By:
- Publication type:
- Article
Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 422, doi. 10.1093/neuonc/noaa196
- By:
- Publication type:
- Article
Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 478, doi. 10.1093/neuonc/noaa193
- By:
- Publication type:
- Article
Functional connectivity within glioblastoma impacts overall survival.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 412, doi. 10.1093/neuonc/noaa189
- By:
- Publication type:
- Article
Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 400, doi. 10.1093/neuonc/noaa188
- By:
- Publication type:
- Article
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 457, doi. 10.1093/neuonc/noaa168
- By:
- Publication type:
- Article
Pulsed radiation therapy for the treatment of newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 447, doi. 10.1093/neuonc/noaa165
- By:
- Publication type:
- Article